These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. New thiazolidine-2,4-diones as effective anti-proliferative and anti-VEGFR-2 agents: Design, synthesis, in vitro, docking, MD simulations, DFT, ADMET, and toxicity studies. Elkady H; Abuelkhir AA; Rashed M; Taghour MS; Dahab MA; Mahdy HA; Elwan A; Al-Ghulikah HA; Elkaeed EB; Ibrahim IM; Husein DZ; Metwaly A; Eissa IH Comput Biol Chem; 2023 Dec; 107():107958. PubMed ID: 37714080 [TBL] [Abstract][Full Text] [Related]
28. Discovery of new quinoline and isatine derivatives as potential VEGFR-2 inhibitors: design, synthesis, antiproliferative, docking and MD simulation studies. Taghour MS; Elkady H; Eldehna WM; El-Deeb N; Kenawy AM; Abd El-Wahab AE; Elkaeed EB; Alsfouk BA; Metwaly AM; Eissa IH J Biomol Struct Dyn; 2023; 41(21):11535-11550. PubMed ID: 36617888 [TBL] [Abstract][Full Text] [Related]
29. New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, anti-proliferative evaluation, flowcytometric analysis, and Elkady H; Elwan A; El-Mahdy HA; Doghish AS; Ismail A; Taghour MS; Elkaeed EB; Eissa IH; Dahab MA; Mahdy HA; Khalifa MM J Enzyme Inhib Med Chem; 2022 Dec; 37(1):397-410. PubMed ID: 34961427 [TBL] [Abstract][Full Text] [Related]
30. Design and synthesis of new 2-oxoquinoxalinyl-1,2,4-triazoles as antitumor VEGFR-2 inhibitors. Zengin M; Unsal Tan O; Arafa RK; Balkan A Bioorg Chem; 2022 Apr; 121():105696. PubMed ID: 35217379 [TBL] [Abstract][Full Text] [Related]
32. Design and synthesis of novel hexahydrobenzo[4,5]thieno[2,3-d]pyrimidine derivatives as potential anticancer agents with antiangiogenic activity via VEGFR-2 inhibition, and down-regulation of PI3K/AKT/mTOR signaling pathway. Seif SE; Mahmoud Z; Wardakhan WW; Abdou AM; Hassan RA Drug Dev Res; 2023 Aug; 84(5):839-860. PubMed ID: 37016480 [TBL] [Abstract][Full Text] [Related]
33. Novel VEGFR-2 inhibitors as antiangiogenic and apoptotic agents via paracrine and autocrine cascades: Design, synthesis, and biological evaluation. Abdel Rahman DE; Fouad MA; Mohammed ER; El-Zoheiry HH; Abdelrasheed Allam H Bioorg Chem; 2023 Oct; 139():106678. PubMed ID: 37354661 [TBL] [Abstract][Full Text] [Related]
34. New quinoxaline derivatives as VEGFR-2 inhibitors with anticancer and apoptotic activity: Design, molecular modeling, and synthesis. Alsaif NA; Dahab MA; Alanazi MM; Obaidullah AJ; Al-Mehizia AA; Alanazi MM; Aldawas S; Mahdy HA; Elkady H Bioorg Chem; 2021 May; 110():104807. PubMed ID: 33721808 [TBL] [Abstract][Full Text] [Related]
35. Design, Synthesis, biological Evaluation, and molecular docking studies of novel Pyrazolo[3,4-d]Pyrimidine derivative scaffolds as potent EGFR inhibitors and cell apoptosis inducers. Sherbiny FF; Bayoumi AH; El-Morsy AM; Sobhy M; Hagras M Bioorg Chem; 2021 Nov; 116():105325. PubMed ID: 34507234 [TBL] [Abstract][Full Text] [Related]
36. The effect of novel synthetic semicarbazone- and thiosemicarbazone-linked 1,2,3-triazoles on the apoptotic markers, VEGFR-2, and cell cycle of myeloid leukemia. Othman EM; Fayed EA; Husseiny EM; Abulkhair HS Bioorg Chem; 2022 Oct; 127():105968. PubMed ID: 35728289 [TBL] [Abstract][Full Text] [Related]
37. Synthesis of novel nicotinic acid derivatives of potential antioxidant and anticancer activity. El-Dash Y; Khalil NA; Ahmed EM; Hassanin SO; Gowifel AMH; Hassan MSA Arch Pharm (Weinheim); 2023 Dec; 356(12):e2300250. PubMed ID: 37792247 [TBL] [Abstract][Full Text] [Related]
38. Design and discovery of thioether and nicotinamide containing sorafenib analogues as multikinase inhibitors targeting B-Raf, B-Raf Sun S; He Z; Huang M; Wang N; He Z; Kong X; Yao J Bioorg Med Chem; 2018 May; 26(9):2381-2391. PubMed ID: 29631788 [TBL] [Abstract][Full Text] [Related]
39. Novel 3-phenylquinazolin-2,4(1H,3H)-diones as dual VEGFR-2/c-Met-TK inhibitors: design, synthesis, and biological evaluation. Hassan A; Mosallam AM; Ibrahim AOA; Badr M; Abdelmonsef AH Sci Rep; 2023 Oct; 13(1):18567. PubMed ID: 37903949 [TBL] [Abstract][Full Text] [Related]
40. Design, synthesis, in vitro antiproliferative evaluation and in silico studies of new VEGFR-2 inhibitors based on 4-piperazinylquinolin-2(1H)-one scaffold. Hassan A; Badr M; Abdelhamid D; Hassan HA; Abourehab MAS; Abuo-Rahma GEA Bioorg Chem; 2022 Mar; 120():105631. PubMed ID: 35091289 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]